I recommend you to take a look at this interesting article from the outgoing chief of Eli Lilly.
Eli Lilly's Sidney Taurel: 'Tailored Therapeutics' -- the Pharmaceutical Industry's Next Blockbuster?
It discuss the changing focus on the Pharma Industry. These changes will impact all you outsourcing experts.
The new paradigm is going to be smaller, quicker, cheaper.
Posts
Why should-cost models aren’t sufficient to drive market-competitive cost
structures
-
Apple has made famous the use of “should-cost” modeling and benchmarking as
a cornerstone of effective procurement organizations for the past few
decades...
No comments:
Post a Comment